Abstract
The General Pharmaceutical Council (GPhC) has investigated eight complaints around sodium valproate and the Pregnancy Prevention Programme (PPP) from the charity INFACT, which supports people who have taken the medicine during pregnancy. Sodium valproate is prescribed for epilepsy and bipolar disorder; however, it can significantly increase developmental disorders and birth defects in babies when taken […]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
